316 related articles for article (PubMed ID: 8393609)
1. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
Smith P
Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
[TBL] [Abstract][Full Text] [Related]
2. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
3. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
Smith P; Heimer G; Lindskog M; Ulmsten U
Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
[TBL] [Abstract][Full Text] [Related]
4. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
6. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
Manonai J; Theppisai U; Chittacharoen A
J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
[TBL] [Abstract][Full Text] [Related]
7. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
8. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
Sarkar NN
Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
[TBL] [Abstract][Full Text] [Related]
9. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
Casper F; Petri E; Benninghoff B
Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
[TBL] [Abstract][Full Text] [Related]
10. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
Bachmann G
J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
12. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
13. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
[TBL] [Abstract][Full Text] [Related]
14. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
Utian WH; Speroff L; Ellman H; Dart C
Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
[TBL] [Abstract][Full Text] [Related]
15. A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.
Henriksson L; Stjernquist M; Boquist L; Cedergren I; Selinus I
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):85-92. PubMed ID: 8572039
[TBL] [Abstract][Full Text] [Related]
16. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse.
Reay Jones NH; Healy JC; King LJ; Saini S; Shousha S; Allen-Mersh TG
Br J Surg; 2003 Apr; 90(4):466-72. PubMed ID: 12673750
[TBL] [Abstract][Full Text] [Related]
17. Vaginal hormone therapy for urogenital and menopausal symptoms.
Ballagh SA
Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
[TBL] [Abstract][Full Text] [Related]
18. Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.
Casper F; Petri E
Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(3):171-6. PubMed ID: 10430010
[TBL] [Abstract][Full Text] [Related]
19. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
20. Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Ben-Chetrit A; Hochner-Celnikier D; Lindenberg T; Zacut D; Shimonovitz S; Gelber H; Spitz IM
Isr Med Assoc J; 2005 May; 7(5):302-6. PubMed ID: 15909462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
